Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Sanofi
02 1Biocon
03 1Biocon Biologics
04 4Biosimilar Collaborations Ireland Limited
05 113Novo Nordisk
06 1ORIFARM GROUP AS
01 4CAT
02 1Flextouch Injectable Solution In Pre-Filled Pen
03 1INJ
04 10INJECTABLE;SUBCUTANEOUS
05 3INJECTION;SOLUTION
06 2Injectable Solution
07 1Injectable Solution In A Pre-Filled Pen
08 3Injectable Solution In Cartridge
09 1Injectable Solution In Pre-Filled Pen
10 2Injectable Solution In Vial
11 1Injectable Suspension
12 3Injection
13 7Injection Solution
14 1Insulin Aspart 160U 1,6Ml 5 Units Parenteral Use
15 2Insulin Aspart 300Iu 3Ml 5 Units Parenteral Use
16 3PED
17 2PFP
18 1Penfill Injectable Solution In Cartridge
19 1Pumpcart Injectable Solution In Cartridge
20 9SOLUTION
21 1SOLUTION;INTRAVENOUS, SUBCUTANEOUS
22 3SOLUTION;SUBCUTANEOUS
23 2SUSPENSION
24 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 30/70 300Iu 3Ml 5 Units Parenteral Use
25 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 50/50 300Iu 3Ml 5 Units Parenteral Use
26 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 70/30 300Iu 3Ml 5 Units Parenteral Use
27 43Solution For Injection
28 16Suspension For Injection
29 4Blank
01 11Allowed
02 9Authorized
03 11Marketed
04 10Originator
05 46Prescription
06 11Schedule D
07 32Blank
01 4FIASP
02 1FIASP FLEXTOUCH
03 1FIASP PENFILL
04 14Fiasp
05 1Fiasp Eml ultra-fast-acting PumpCart
06 1Fiasp Flextouch
07 2Fiasp Penfill
08 1Fiasp Pumpcart
09 1Fiasp ultra-fast-acting
10 1Fiasp ultra-fast-acting FlexTouch
11 1Fiasp ultra-fast-acting Penfill
12 3Insulin Aspart "Sanofi"
13 1Insulin NovoNordisk NovoRapid
14 1Insulin NovoNordisk NovoRapid FlexPen
15 1Insulin NovoNordisk NovoRapid FlexTouch
16 1Insulin NovoNordisk NovoRapid Penfill
17 1Insulin NovoNordisk NovoRapid PumpCart Eml
18 2KIRSTY
19 4Kirsty
20 1MERILOG
21 1MERILOG SOLOSTAR
22 1NOVOLOG
23 1NOVOLOG FLEXPEN
24 1NOVOLOG FLEXTOUCH
25 1NOVOLOG INNOLET
26 1NOVOLOG MIX 50/50
27 1NOVOLOG MIX 70/30
28 1NOVOLOG MIX 70/30 FLEXPEN
29 2NOVOLOG MIX 70/30 PENFILL
30 1NOVOLOG PENFILL
31 2NOVOMIX 30
32 2NOVORAPID
33 2NovoMix 30
34 1NovoMix 30 FlexPen
35 1NovoMix 30 Penfill 3 mL
36 5NovoRapid
37 1NovoRapid FlexPen
38 2NovoRapid Flexpen
39 1NovoRapid Penfill
40 1NovoRapid Penfill 3 mL
41 1NovoRapid PumpCart
42 1NovoRapid® FlexPen®
43 1NovoRapid® Penfill®
44 3Novomix
45 1Novomix 30
46 2Novomix 30 Flexpen
47 1Novomix 30 Flexpen 100 U/ml
48 1Novomix 30 Novolet
49 2Novomix 30 Penfill
50 1Novomix 30 Penfill 100 U/ml
51 2Novomix 50 Flexpen
52 2Novomix 50 Penfill
53 2Novomix 70 Flexpen
54 1Novomix 70 Penfill
55 4Novorapid
56 1Novorapid Flex Touch
57 4Novorapid Flexpen
58 1Novorapid Flextouch
59 2Novorapid Innolet
60 3Novorapid Penfill
61 3Novorapid Pumpcart
62 1Novorapidfill
63 1RYZODEG 70/30
64 1Ryzodeg
65 1Ryzodeg 100 Flextouch
66 1Ryzodeg 100 Penfill
67 1Ryzodeg 100 Ãœhikut/Ml Flexpen
68 1Ryzodeg 100 Ãœhikut/Ml Flextouch
69 1Ryzodeg 100 Ãœhikut/Ml Penfill
70 1Ryzodeg FlexTouch
71 2Ryzodeg Penfill
72 3Ryzodeg®
73 3TRURAPI
74 2Truvelog Mix 30
01 7Australia
02 11Canada
03 26Denmark
04 20Estonia
05 6Italy
06 2Moldova
07 11Norway
08 10South Africa
09 9Spain
10 11Switzerland
11 17USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : MERILOG
Dosage Form : INJECTION;SOLUTION
Dosage Strength : 10ML(100UNITS/ML)
Packaging :
Approval Date :
Application Number : 761325
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : MERILOG SOLOSTAR
Dosage Form : INJECTION;SOLUTION
Dosage Strength : 3ML(100UNITS/ML)
Packaging :
Approval Date :
Application Number : 761325
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2506564
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2506572
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2529254
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Insulin Aspart \"Sanofi\"
Dosage Form : Injection Solution
Dosage Strength : 100 U/ml
Packaging :
Approval Date : 21-02-2021
Application Number : 28106486720
Regulatory Info : Prescription
Registration Country : Denmark
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Insulin Aspart \"Sanofi\"
Dosage Form : Solution For Injection
Dosage Strength : 100 U/ml
Packaging :
Approval Date : 25-06-2020
Application Number : 28106283519
Regulatory Info : Prescription
Registration Country : Denmark
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Insulin Aspart \"Sanofi\"
Dosage Form : Solution For Injection
Dosage Strength : 100 U/ml
Packaging :
Approval Date : 25-06-2020
Application Number : 28106474719
Regulatory Info : Prescription
Registration Country : Denmark
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Truvelog Mix 30
Dosage Form : Injectable Suspension
Dosage Strength : 100 units/ml
Packaging :
Approval Date : 25-04-2022
Application Number : 28106607521
Regulatory Info : Prescription
Registration Country : Denmark
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Truvelog Mix 30
Dosage Form : Suspension For Injection
Dosage Strength : 100 units/ml
Packaging :
Approval Date : 25-04-2022
Application Number : 28106607621
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG FLEXPEN
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG INNOLET
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG FLEXTOUCH
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 700 UNITS/10ML; 300 UNITS/10ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 FLEXPEN
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 50/50
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 50 UNITS/ML;50 UNITS/ML
Packaging :
Approval Date :
Application Number : 21810
Regulatory Info :
Registration Country : USA
